Evidence map›Paper›PMID 26106861›Full record

ArticleNature2015

The core spliceosome as target and effector of non-canonical ATM signalling.

Maria Tresini, Daniël O Warmerdam, Petros Kolovos, Loes Snijder, Mischa G Vrouwe, Jeroen A A Demmers, Wilfred F J van IJcken, Frank G Grosveld, René H Medema, Jan H J Hoeijmakers and 3 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 168 papers.

0numbers the graph read from it
0cells of the map it votes in
168citing papers in PubMed
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

168 citing papers in PubMed, 252 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

108 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Maria TresiniDepartment of Genetics, Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015 CN, The Netherlands.
Daniël O WarmerdamDivision of Cell Biology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands.
Petros KolovosDepartment of Cell Biology, Erasmus University Medical Center, Rotterdam, 3015 CN, The Netherlands.
Loes SnijderDepartment of Genetics, Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015 CN, The Netherlands.
Mischa G VrouweDepartment of Human Genetics, Leiden University Medical Center, Leiden, 2333 ZC, The Netherlands.
Jeroen A A DemmersErasmus MC Proteomics Center, Erasmus University Medical Center, Rotterdam, 3015 CN, The Netherlands.
Wilfred F J van IJckenErasmus Center for Biomics, Erasmus University Medical Center, Rotterdam, 3015 CN, The Netherlands.
Frank G GrosveldDepartment of Cell Biology, Erasmus University Medical Center, Rotterdam, 3015 CN, The Netherlands.
René H MedemaDivision of Cell Biology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands.
Jan H J HoeijmakersDepartment of Genetics, Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015 CN, The Netherlands.
Leon H F MullendersDepartment of Human Genetics, Leiden University Medical Center, Leiden, 2333 ZC, The Netherlands.
Wim VermeulenDepartment of Genetics, Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015 CN, The Netherlands.
Jurgen A MarteijnDepartment of Genetics, Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015 CN, The Netherlands.
Erasmus MC · NLLeiden University Medical Center · NLThe Netherlands Cancer Institute · NLCancer Genomics Centre · NL

Funding

THE IMPACT OF CELLULAR DEFENSE ON THE ROLE OF Ku80 IN GENOME MAINTENANCE AND LONGP01AG017242 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI VIJG, JAN · 1999 to 2023
$46.1M
European Research Council 233424European Research Council 340988NIA NIH HHS P01 AG017242Worldwide Cancer Research 10-0594
6 · The paper itself

Abstract

In response to DNA damage, tissue homoeostasis is ensured by protein networks promoting DNA repair, cell cycle arrest or apoptosis. DNA damage response signalling pathways coordinate these processes, partly by propagating gene-expression-modulating signals. DNA damage influences not only the abundance of messenger RNAs, but also their coding information through alternative splicing. Here we show that transcription-blocking DNA lesions promote chromatin displacement of late-stage spliceosomes and initiate a positive feedback loop centred on the signalling kinase ATM. We propose that initial spliceosome displacement and subsequent R-loop formation is triggered by pausing of RNA polymerase at DNA lesions. In turn, R-loops activate ATM, which signals to impede spliceosome organization further and augment ultraviolet-irradiation-triggered alternative splicing at the genome-wide level. Our findings define R-loop-dependent ATM activation by transcription-blocking lesions as an important event in the DNA damage response of non-replicating cells, and highlight a key role for spliceosome displacement in this process.

Indexed as

Signal TransductionAlternative SplicingAtaxia Telangiectasia Mutated ProteinsCell LineChromatinDNA DamageDNA-Directed RNA PolymerasesEnzyme ActivationHumansSpliceosomesUltraviolet RaysAtaxia Telangiectasia Mutated ProteinsChromatinDNA-Directed RNA Polymerases

Identifiers

PMID26106861
PMCPMC4501432
OpenAlexW1823908009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.